SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001214659-23-015583
Filing Date
2023-11-28
Accepted
2023-11-27 20:57:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 j1121230f1a1.htm F-1/A 1245221
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 6526
3 EXHIBIT 107 ex107.htm EX-FILING FEES 30680
4 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
5 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
6 GRAPHIC pipeline1.jpg GRAPHIC 34967
7 GRAPHIC pipeline2.jpg GRAPHIC 18978
  Complete submission text file 0001214659-23-015583.txt   1391223
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-274895 | Film No.: 231441698
SIC: 2834 Pharmaceutical Preparations